Twenty‐nine years into the HIV epidemic, several advances have been made; however,
there remain several challenges particularly with pediatric HIV in resource‐limited countries …

Laboratory monitoring of HIV-infected children is the current standard of care in the United
States to guide the appropriate use of antiretroviral therapy (ART). Although ART is …

BACKGROUND: No trials have investigated routine laboratory monitoring for children with
HIV, nor four-drug induction strategies to increase durability of first-line antiretroviral therapy …

BACKGROUND: Worldwide access to antiretroviral therapy (ART) in low-and middle-income
countries has significantly increased. Although this presents better treatment options for HIV …

Introduction The objective of this commentary is to review considerations for implementing
routine viral load (VL) monitoring programmes for HIV‐infected infants and children living in …

Laboratory monitoring is recommended for CD4 and every six months. Viral load at least at 6
and 12 months after initiation or change of regimen, then yearly thereafter. More frequent …

Objectives: To conduct two economic analyses addressing whether to: routinely monitor HIV-
infected children on antiretroviral therapy (ART) clinically or with laboratory tests; continue or …

Combination antiretroviral therapy (cART) has transformed pediatric HIV infection in
resource-rich countries from a fatal infection to a treatable chronic disease. Children treated …

There has been a dramatic and commendable rapid scale-up of human immunodeficiency
virus (HIV) prevention and care services in resource-limited settings, including sub-Saharan …

Objective: Antiretroviral therapy (ART) management for HIV-infected children is critical in
many resource-constrained countries. We investigated the cost-effectiveness and cost-utility …